Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 625.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.48 billion as of August 26, 2026. Its market cap has decreased by -18.44% in one year.
Market Cap
3.48B
Enterprise Value
2.14B
Revenue
1.42B
Ranking
n/a
PE Ratio
17.54
Stock Price
625.00
ChartMarket Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.48B, a decrease of -68.51%. That is a compound annual growth rate of -8.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 3.48B | -6.92% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.63B |
| D. Western Therapeutics Institute | 5.06B |
| TMS Co., Ltd. | 5.02B |
| J-Pharma | 4.95B |
| Ribomic | 4.75B |
| Kohjin Bio | 4.32B |
| Transgenic Group | 4.28B |
| Kringle Pharma | 3.60B |